Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for blood loss reduction in intertrochanteric hip fracture surgery
ACTRN12620001059954Phase 3Completed
- Sponsor
- Dr. Faaiz Ali Shah
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tranexamic acid in hip fracture and intertrochanteric fracture, sponsored by Dr. Faaiz Ali Shah. Started Jan 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hip fractureintertrochanteric fracture
Beyond the preview
Go deeper on ACTRN12620001059954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001059954.